With new data, Nkarta builds case for ‘natural killer’ cell therapy

With new data, Nkarta builds case for ‘natural killer’ cell therapy

Source: 
BioPharma Dive
snippet: 

Nkarta, a leading developer of an emerging form of cancer cell therapy, on Monday reported updated results from an early study testing one of its blood cancer treatments.